The global cervical cancer burden falls disproportionately upon women in low and middle-income countries. Insufficient infrastructure, lack of access to preventive HPV vaccines, screening, and treatment, as well as limited trained personnel and training opportunities, continue to impede efforts to reduce incidence and mortality in these nations. These hurdles have been substantial challenges to radiation delivery in particular, preventing treatment for a disease in which radiation is a cornerstone of curative therapy. In this review, we discuss the breadth of these barriers, while illustrating the need for adaptive approaches by proposing the use of brachytherapy alone in the absence of available external beam radiotherapy. Such modificatio...
Introduction Despite the availability of an effective human papillomavirus (HPV) vaccine and early s...
Cervical cancer (CC) is the leading cause of cancer-related death among women in sub-Saharan Africa,...
In developed countries, systematic screening programmes have reduced the morbidity and mortality res...
IntroductionBrachytherapy is an essential component of the cervical cancer treatment paradigm as it ...
Cervical cancer represents a significant portion of the global cancer burden for women, with low- an...
Gynecologic carcinomas, including cervical cancer, present a significant burden on low- and middle-i...
Human papillomaviruses (HPV)-related gynecological cancers are a major health care issue, and a lead...
A disproportionate burden of gynecologic malignancies occurs in low- and middle-income countries. Ra...
Virtually all cases of invasive cervical cancer are associated with infection by high-risk strains o...
Breast and cervical cancers are the commonest cancers diagnosed in women living in low-income and mi...
Early detection concomitant with appropriate treatment intervention for pre-invasive cervical cancer...
Cervical cancer is one of the most common cancers among women worldwide, and approximately 85% of ne...
Background: Cervical cancer (CCa) and breast cancer (BCa) are the two leading cancers in women world...
AbstractEach year, 200,000 more women die from breast and cervical cancer than from pregnancy and ch...
Background: Cervical cancer (CCa) and breast cancer (BCa) are the two leading cancers in women world...
Introduction Despite the availability of an effective human papillomavirus (HPV) vaccine and early s...
Cervical cancer (CC) is the leading cause of cancer-related death among women in sub-Saharan Africa,...
In developed countries, systematic screening programmes have reduced the morbidity and mortality res...
IntroductionBrachytherapy is an essential component of the cervical cancer treatment paradigm as it ...
Cervical cancer represents a significant portion of the global cancer burden for women, with low- an...
Gynecologic carcinomas, including cervical cancer, present a significant burden on low- and middle-i...
Human papillomaviruses (HPV)-related gynecological cancers are a major health care issue, and a lead...
A disproportionate burden of gynecologic malignancies occurs in low- and middle-income countries. Ra...
Virtually all cases of invasive cervical cancer are associated with infection by high-risk strains o...
Breast and cervical cancers are the commonest cancers diagnosed in women living in low-income and mi...
Early detection concomitant with appropriate treatment intervention for pre-invasive cervical cancer...
Cervical cancer is one of the most common cancers among women worldwide, and approximately 85% of ne...
Background: Cervical cancer (CCa) and breast cancer (BCa) are the two leading cancers in women world...
AbstractEach year, 200,000 more women die from breast and cervical cancer than from pregnancy and ch...
Background: Cervical cancer (CCa) and breast cancer (BCa) are the two leading cancers in women world...
Introduction Despite the availability of an effective human papillomavirus (HPV) vaccine and early s...
Cervical cancer (CC) is the leading cause of cancer-related death among women in sub-Saharan Africa,...
In developed countries, systematic screening programmes have reduced the morbidity and mortality res...